• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过靶向SIGN-R1巨噬细胞的疫苗诱导的低频CD8 T细胞可清除小鼠体内的新冠病毒。

Low-frequency CD8 T cells induced by SIGN-R1 macrophage-targeted vaccine confer SARS-CoV-2 clearance in mice.

作者信息

Muraoka Daisuke, Moi Meng Ling, Muto Osamu, Nakatsukasa Takaaki, Deng Situo, Takashima Chieko, Yamaguchi Rui, Sawada Shin-Ichi, Hayakawa Haruka, Nguyen Thi Thanh Ngan, Haseda Yasunari, Soga Takatoshi, Matsushita Hirokazu, Ikeda Hiroaki, Akiyoshi Kazunari, Harada Naozumi

机构信息

Department of Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan.

出版信息

NPJ Vaccines. 2024 Sep 18;9(1):173. doi: 10.1038/s41541-024-00961-6.

DOI:10.1038/s41541-024-00961-6
PMID:39294173
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11411095/
Abstract

Vaccine-induced T cells and neutralizing antibodies are essential for protection against SARS-CoV-2. Previously, we demonstrated that an antigen delivery system, pullulan nanogel (PNG), delivers vaccine antigen to lymph node medullary macrophages and thereby enhances the induction of specific CD8 T cells. In this study, we revealed that medullary macrophage-selective delivery by PNG depends on its binding to a C-type lectin SIGN-R1. In a K18-hACE2 mouse model of SARS-CoV-2 infection, vaccination with a PNG-encapsulated receptor-binding domain of spike protein decreased the viral load and prolonged the survival in the CD8 T cell- and B cell-dependent manners. T cell receptor repertoire analysis revealed that although the vaccine induced T cells at various frequencies, low-frequency specific T cells mainly promoted virus clearance. Thus, the induction of specific CD8 T cells that respond quickly to viral infection, even at low frequencies, is important for vaccine efficacy and can be achieved by SIGN-R1 medullary macrophage-targeted antigen delivery.

摘要

疫苗诱导的T细胞和中和抗体对于预防新型冠状病毒(SARS-CoV-2)至关重要。此前,我们证明了一种抗原递送系统,即支链淀粉纳米凝胶(PNG),可将疫苗抗原递送至淋巴结髓质巨噬细胞,从而增强特异性CD8 T细胞的诱导。在本研究中,我们发现PNG对髓质巨噬细胞的选择性递送取决于其与C型凝集素SIGN-R1的结合。在SARS-CoV-2感染的K18-hACE2小鼠模型中,用包裹刺突蛋白受体结合域的PNG进行疫苗接种以依赖CD8 T细胞和B细胞的方式降低了病毒载量并延长了生存期。T细胞受体库分析表明,尽管疫苗以不同频率诱导T细胞,但低频特异性T细胞主要促进病毒清除。因此,即使在低频下,诱导对病毒感染快速反应的特异性CD8 T细胞对于疫苗效力很重要,并且可以通过靶向SIGN-R1髓质巨噬细胞的抗原递送来实现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/513bc09797d2/41541_2024_961_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/ff08f26a699d/41541_2024_961_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/71893319d85f/41541_2024_961_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/4b11beb31853/41541_2024_961_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/17dd2e63e6be/41541_2024_961_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/729063e75bea/41541_2024_961_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/2ddf200af321/41541_2024_961_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/513bc09797d2/41541_2024_961_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/ff08f26a699d/41541_2024_961_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/71893319d85f/41541_2024_961_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/4b11beb31853/41541_2024_961_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/17dd2e63e6be/41541_2024_961_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/729063e75bea/41541_2024_961_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/2ddf200af321/41541_2024_961_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c87b/11411095/513bc09797d2/41541_2024_961_Fig7_HTML.jpg

相似文献

1
Low-frequency CD8 T cells induced by SIGN-R1 macrophage-targeted vaccine confer SARS-CoV-2 clearance in mice.通过靶向SIGN-R1巨噬细胞的疫苗诱导的低频CD8 T细胞可清除小鼠体内的新冠病毒。
NPJ Vaccines. 2024 Sep 18;9(1):173. doi: 10.1038/s41541-024-00961-6.
2
Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain.mRNA 疫苗对小鼠进行同侧或对侧增强免疫可提供针对 SARS-CoV-2 奥密克戎株的等效免疫和保护。
J Virol. 2024 Sep 17;98(9):e0057424. doi: 10.1128/jvi.00574-24. Epub 2024 Aug 28.
3
A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection.第三次接种单一 T 细胞表位可在 SARS-CoV-2 感染的小鼠模型中提供保护。
Nat Commun. 2022 Jul 8;13(1):3966. doi: 10.1038/s41467-022-31721-6.
4
A Synthetic SARS-CoV-2-Derived T-Cell and B-Cell Peptide Cocktail Elicits Full Protection against Lethal Omicron BA.1 Infection in H11-K18-hACE2 Mice.一种合成的源自严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的T细胞和B细胞肽混合物可对H11-K18-hACE2小鼠的致死性奥密克戎BA.1感染提供完全保护。
Microbiol Spectr. 2023 Mar 13;11(2):e0419422. doi: 10.1128/spectrum.04194-22.
5
MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses.基于 MVA 的疫苗候选物表达了武汉、β或奥密克戎 BA.1 变异株的 prefusion-稳定化 Spike 蛋白,可保护 K18-hACE2 转基因小鼠免受奥密克戎感染,并引发强烈和广泛的特异性体液和细胞免疫反应。
Front Immunol. 2024 Aug 29;15:1420304. doi: 10.3389/fimmu.2024.1420304. eCollection 2024.
6
Vaccine-associated respiratory pathology correlates with viral clearance and protective immunity after immunization with self-amplifying RNA expressing the spike (S) protein of SARS-CoV-2 in mouse models.疫苗相关呼吸道病理学与病毒清除和保护性免疫有关,在小鼠模型中,使用表达 SARS-CoV-2 刺突(S)蛋白的自我扩增 RNA 免疫后。
Vaccine. 2024 Jan 25;42(3):608-619. doi: 10.1016/j.vaccine.2023.12.052. Epub 2023 Dec 23.
7
Intranasal Delivery of MVA Vector Vaccine Induces Effective Pulmonary Immunity Against SARS-CoV-2 in Rodents.鼻腔内递送 MVA 载体疫苗可在啮齿动物中诱导针对 SARS-CoV-2 的有效肺部免疫。
Front Immunol. 2021 Nov 11;12:772240. doi: 10.3389/fimmu.2021.772240. eCollection 2021.
8
COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice.基于表达严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的改良安卡拉痘苗病毒的新型冠状病毒肺炎(COVID-19)候选疫苗可在小鼠体内诱导强烈的T细胞和B细胞免疫反应及完全效力。
J Virol. 2021 Mar 10;95(7). doi: 10.1128/JVI.02260-20. Epub 2021 Jan 7.
9
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.杂合免疫改变了 SARS-CoV-2 mRNA 疫苗诱导免疫的 Fc 效应子质量。
mBio. 2022 Oct 26;13(5):e0164722. doi: 10.1128/mbio.01647-22. Epub 2022 Aug 24.
10
Neutralizing antibody and CD8 T cell responses following BA.4/5 bivalent COVID-19 booster vaccination in adults with and without prior exposure to SARS-CoV-2.BA.4/5 二价 COVID-19 加强疫苗接种后对有和无 SARS-CoV-2 既往暴露的成年人的中和抗体和 CD8 T 细胞应答。
Front Immunol. 2024 Mar 20;15:1353353. doi: 10.3389/fimmu.2024.1353353. eCollection 2024.

本文引用的文献

1
Natural killer cells in COVID-19: from infection, to vaccination and therapy.新冠病毒疾病中的自然杀伤细胞:从感染到疫苗接种及治疗
Future Virol. 2023 Feb. doi: 10.2217/fvl-2022-0040. Epub 2023 Mar 14.
2
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models.双刺突和核衣壳 mRNA 疫苗接种可预防临床前模型中的 SARS-CoV-2 奥密克戎和德尔塔变异株。
Sci Transl Med. 2022 Sep 14;14(662):eabq1945. doi: 10.1126/scitranslmed.abq1945.
3
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome.
NY-ESO-1 特异性重定向 T 细胞与内源性 TCR 敲低介导肿瘤反应和细胞因子释放综合征。
J Immunother Cancer. 2022 Jun;10(6). doi: 10.1136/jitc-2021-003811.
4
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.关注的新冠病毒变异株的生物学功能及临床意义
Front Med (Lausanne). 2022 May 20;9:849217. doi: 10.3389/fmed.2022.849217. eCollection 2022.
5
Bioengineered nanogels for cancer immunotherapy.用于癌症免疫治疗的生物工程纳米凝胶。
Chem Soc Rev. 2022 Jun 20;51(12):5136-5174. doi: 10.1039/d2cs00247g.
6
Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants.疫苗诱导的针对 SARS-CoV-2 病毒变异株的全身和黏膜 T 细胞免疫。
Proc Natl Acad Sci U S A. 2022 May 17;119(20):e2118312119. doi: 10.1073/pnas.2118312119. Epub 2022 May 13.
7
Self-assembled polysaccharide nanogel delivery system for overcoming tumor immune resistance.自组装多糖纳米凝胶递药系统克服肿瘤免疫抵抗。
J Control Release. 2022 Jul;347:175-182. doi: 10.1016/j.jconrel.2022.05.004. Epub 2022 May 11.
8
Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.在 CHP-NY-ESO-1 疫苗辅助治疗的食管癌患者中,NY-ESO-1 抗原和 PIGR 表达的预后意义。
Cancer Immunol Immunother. 2022 Nov;71(11):2743-2755. doi: 10.1007/s00262-022-03194-5. Epub 2022 Apr 16.
9
Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8 T cell responses.非中和抗体依赖的 SARS-CoV-2 控制与鼻内疫苗诱导的 CD8 T 细胞反应相关。
Cell Rep Med. 2022 Jan 19;3(2):100520. doi: 10.1016/j.xcrm.2022.100520. eCollection 2022 Feb 15.
10
TCR meta-clonotypes for biomarker discovery with enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs.利用 TCR 元克隆型进行生物标志物发现, 能够识别 SARS-CoV-2 TCR 的公共、HLA 限制簇。
Elife. 2021 Nov 30;10:e68605. doi: 10.7554/eLife.68605.